We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EQT:OMXSTOEQT AB Analysis

Data as of 2026-09-09 - not real-time

$54.63

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

The moving-average structure behind EQT Corporation is neutral at $54.63, with no clear ordering between short and long averages. The last 30 days have gained 5.7%. RSI sits at 54.4, which reads as neutral, and MACD momentum is bearish. Price has been bracketed by support at $52.38 and resistance at $56.52.
Valuation screens as undervalued: a P/E of 12.7 sits below the sector average of 18.1. The average analyst target implies 23.4% above today's level. Revenue is contracting at 3.9% on a 29.2% profit margin. The 1.20% dividend yield looks covered by current payout levels.
The composite risk read is 3/10, putting it in low territory. With 30-day volatility of 22.0%, a beta of 0.12 and a maximum drawdown of 28.1%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
This one splits by horizon — hold in the near term, buy further out, at 6/10 long-term conviction.

Top Market Events

Headquartered in Canonsburg, Pennsylvania, EQT Corporation EQT explores, produces, gathers, and transports natural gas...EQT stock reflects a busy August 17, 2026, with the group completing the sale of a 20-property U.Detailed price information for Eqt Corp EQT-N from The Globe and Mail including charting and trades.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • Trading below the 200-day average of 56.11
  • MACD momentum is negative
  • 30-day price change of +5.7%

Medium Term

1–3 years
Positive
Model confidence: 4/10

Key Factors

  • P/E of 12.7 versus sector average of 18.1
  • Trading below the 200-day average of 56.11
  • Analyst targets imply +23.4% versus the current price

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • P/E of 12.7 versus sector average of 18.1
  • Analyst targets imply +23.4% versus the current price
  • Profit margin of 29.2% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth-3.90%
Profit Margin29.18%
P/E Ratio12.7
ROE11.08%
ROA6.63%
Debt/Equity19.59
P/B Ratio1.4
Op. Cash Flow$6.2B
Free Cash Flow$2.5B
Industry P/E18.1

Technical Analysis

TrendNeutral
RSI54.4
Support$52.38
Resistance$56.52
MA 20$54.40
MA 50$52.77
MA 200$56.11
MACDBearish
VolumeStable
Fear & Greed Index92.04

Valuation

Fair Value$40.74
Target Price$67.44
Upside/Downside23.45%
GradeUndervalued
TypeValue
Dividend Yield1.20%

Risk Assessment

Beta0.12
Volatility22.01%
Sector RiskHigh
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.